Clinical Trial Update: A Study of Atezolizumab With Lenvatinib or Sorafenib Versus Lenvatinib or Sorafenib Alone in Hepatocellular Carcinoma Previously Treated With Atezolizumab and Bevacizumab [Phase 3]

View source ↗

Summary

Phase 3 study evaluating atezolizumab plus lenvatinib or sorafenib versus lenvatinib or sorafenib alone in unresectable hepatocellular carcinoma after prior ate…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Atezolizumab (atezolizumab)
• Bevacizumab (bevacizumab)
• Lenvatinib (lenvatinib)
• Sorafenib (Sorafenib)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Unresectable Hepatocellular Carcinoma | Phase 3 | Status: ACTIVE_NOT_RECRUITING